Royal Philips has received the US Food and Drug Administration (FDA) 510(k) clearance for Philips IntelliSite Pathology Solution 5.1, the latest generation of its digital pathology solution.
Philips IntelliSite Pathology is designed to support remote collaboration, enhance teamwork, support diagnosis, increase productivity, address staffing challenges, and reduce costs.
Digital workflows enhance diagnostic accuracy and efficiency by integrating pathology into broader precision diagnostic systems and IT infrastructure.
The integration ensures smoother coordination and communication among healthcare professionals, resulting in more precise and timely diagnoses.
The solution is said to be a comprehensive and scalable platform that integrates hardware, software, storage, analysis tools, and enterprise-wide connectivity.
According to Philips, this integrated approach provides pathologists with seamless, end-to-end digital workflows.
Philips IntelliSite Pathology Solution was first launched in 2017 and became the first FDA-approved digital pathology solution in the market.
Philips clinical informatics business leader Martijn Hartjes said: “With the 510(k) approval we expand our ability to help pathology laboratories transform to fully digital workflows, saving time and easing the burden on pathologists and patients.
“We are advancing the digital transformation in pathology and multi-disciplinary clinical collaboration between pathologists, radiologists, oncologists, and other healthcare professionals, empowering clinicians with the tools they need to deliver improved patient outcomes and care.”
The Philips IntelliSite Pathology Solution accelerates the review, reporting, and sign-off processes for cases, and it also allows pathologists to work remotely.
The Dutch healthcare company claimed that the solution has 21% more efficiency compared to traditional analogue workflows, addressing the current shortage of trained pathologists, and reducing costs.
Both commercial providers and hospital pathology departments can use this solution to meet the increasing demand for pathology services.
The Philips IntelliSite Pathology Solution empowers pathologists by enabling remote collaboration for second opinions and access to advanced cloud-based artificial intelligence (AI) applications.
Additionally, the care teams can access data throughout a patient’s treatment journey, even beyond the confines of the pathology lab.
Furthermore, Philips’ open-platform approach supports secure data sharing, fostering the development of new diagnostic algorithms, disease biomarkers, and treatment options based on extensive digital pathology datasets.
The digital workflow solution also integrates with cloud-based services to allow the incorporation of advanced AI-driven diagnostic applications from third-party providers.
